Question 1

What is the catalog number for 2- (1H-Indol-3-yl) -2-oxoacetaldehyde?

Accepted Answer

The catalog number for 2- (1H-Indol-3-yl) -2-oxoacetaldehyde is HAA26972.

Question 2

What sizes are available for 2- (1H-Indol-3-yl) -2-oxoacetaldehyde?

Accepted Answer

2- (1H-Indol-3-yl) -2-oxoacetaldehyde is available in the following size(s): 50 mg, 0.5 g.

Question 3

How many pack sizes does 2- (1H-Indol-3-yl) -2-oxoacetaldehyde come in?

Accepted Answer

2- (1H-Indol-3-yl) -2-oxoacetaldehyde is available in 2 different pack sizes.

Question 4

Is 2- (1H-Indol-3-yl) -2-oxoacetaldehyde in stock?

Accepted Answer

2- (1H-Indol-3-yl) -2-oxoacetaldehyde is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 7

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

2- (1H-Indol-3-yl) -2-oxoacetaldehyde

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

CD34 (ICO-115), CF640R conjugate, 0.1mg/mL

Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL

P34 / cdk1 (POH-1), CF647 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, 0.1mg/mL

CD8 (C8/468), CF568 conjugate, 0.1mg/mL

CD43 (84-3C1), Biotin conjugate, 0.1mg/mL